Safety and efficacy of pegylated recombinant human granulocyte colony-stimulating factor during concurrent chemoradiotherapy for small-cell lung cancer: a retrospective, cohort-controlled trial

OBJECTIVE: To investigate pegylated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) safety and efficacy in preventing hematological toxicity during concurrent chemoradiotherapy (CCRT) for small-cell lung cancer (SCLC). METHODS: We retrospectively assessed 80 SCLC patients treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Cunliang, Zhu, Shouhui, Miao, Chuanwang, Wang, Yu, Chen, Jiazhen, Yuan, Shuanghu, Hu, Xudong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107159/
https://www.ncbi.nlm.nih.gov/pubmed/35562713
http://dx.doi.org/10.1186/s12885-022-09644-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107159/
https://www.ncbi.nlm.nih.gov/pubmed/35562713
http://dx.doi.org/10.1186/s12885-022-09644-8

Ejemplares similares